Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project
Creator Taprogge et al.
Author Jan Taprogge
Author Francesca Leek
Author Tino Schurrat
Author Johannes Tran-Gia
Author Delphine Vallot
Author Manuel Bardiès
Author Uta Eberlein
Author Michael Lassmann
Author Susanne Schlögl
Author Alex Vergara Gil
Author Glenn D. Flux
Abstract BACKGROUND: Differentiated thyroid cancer has been treated with radioiodine for almost 80?years, although controversial questions regarding radiation-related risks and the optimisation of treatment regimens remain unresolved. Multi-centre clinical studies are required to ensure recruitment of sufficient patients to achieve the statistical significance required to address these issues. Optimisation and standardisation of data acquisition and processing are necessary to ensure quantitative imaging and patient-specific dosimetry. MATERIAL AND METHODS: A European network of centres able to perform standardised quantitative imaging of radioiodine therapy of thyroid cancer patients was set-up within the EU consortium MEDIRAD. This network will support a concurrent series of clinical studies to determine accurately absorbed doses for thyroid cancer patients treated with radioiodine. Five SPECT(/CT) systems at four European centres were characterised with respect to their system volume sensitivity, recovery coefficients and dead time. RESULTS: System volume sensitivities of the Siemens Intevo systems (crystal thickness 3/8?) ranged from 62.1 to 73.5 cps/MBq. For a GE Discovery 670 (crystal thickness 5/8?) a system volume sensitivity of 92.2 cps/MBq was measured. Recovery coefficients measured on three Siemens Intevo systems show good agreement. For volumes larger than 10?ml, the maximum observed difference between recovery coefficients was found to be ± 0.02. Furthermore, dead-time coefficients measured on two Siemens Intevo systems agreed well with previously published dead-time values. CONCLUSIONS: Results presented here provide additional support for the proposal to use global calibration parameters for cameras of the same make and model. This could potentially facilitate the extension of the imaging network for further dosimetry-based studies.
Publication EJNMMI physics
Volume 7
Issue 1
Pages 61
Date 2020-10-08
Journal Abbr EJNMMI Phys
Language eng
DOI 10.1186/s40658-020-00332-9
ISSN 2197-7364
Library Catalog PubMed
Extra Number: 1 PMID: 33030702 PMCID: PMC7544799
Tags Differentiated thyroid cancer, Dosimetry, Multi-centre trial, original, Radioiodine, Scientific
Date Added 2023/11/23 - 12:44:33
Date Modified 2024/12/15 - 11:46:05
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés